Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 10/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22115552 | 1.00 | FDPS (0.44) | FDPSSMPD1GGPS1TP53CES2 | |
| SCHEMBL7563586 | 1.00 | FDPS (0.44) | FDPSSMPD1GGPS1TP53CES2 | |
| SCHEMBL7569184 | 1.00 | FDPS (0.44) | FDPSSMPD1GGPS1TP53CES2 | |
| SCHEMBL27590252 | 0.84 | FDPS (0.37) | FDPS | |
| SCHEMBL22115567 | 0.83 | FDPS (0.43) | FDPSSMPD1GGPS1TP53CES2 | |
| SCHEMBL22115554 | 0.83 | FDPS (0.43) | FDPSSMPD1GGPS1TP53CES2 | |
| SCHEMBL22115556 | 0.81 | FDPS (0.42) | FDPSSMPD1GGPS1TP53CES2 | |
| SCHEMBL22115569 | 0.81 | FDPS (0.42) | FDPSSMPD1GGPS1TP53CES2 | |
| SCHEMBL22115564 | 0.81 | FDPS (0.42) | FDPSSMPD1GGPS1TP53CES2 | |
| Sulfuric Acid SCHEMBL25184770 | 0.78 | SMPD1 (0.48) | FDPSSMPD1GGPS1TP53CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110023325-A | The peptide from fibronectin to Neutrophil elastase degradation neurological susceptibility of bioactivity and reduction with raising | 尼优美特里克斯医疗有限公司 | 2019-07-16 | — | — | CN | disclosed |
| CN-109641030-A | METHODS AND COMPOSITIONS FOR MODULATING OPIOID WITHDRAWAL SYMPTOMS | 优特埃合伙有限公司 | 2019-04-16 | — | — | CN | disclosed |